Corporate creators

Number of items: 2.
HPTN 071 (PopART) Study Team (2021). Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial. The Lancet Global Health, 9(5), e668 - e680. https://doi.org/10.1016/S2214-109X(21)00034-6 HPTN 071 (PopART) Study Team (2017). Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial. The Lancet Global Health, 5(11), e1133 - e1141. https://doi.org/10.1016/S2214-109X(17)30367-4